Kits for the detection of beta-lactamases
Presented herein are kits for the detection of specific beta-lactamases, including class A serine carbapenemases, metallo-beta-lactamases, AmpC beta-lactamases, and extended-spectrum beta-lactamases (ESBLs). The kits presented herein include kits that permit the detection of the presence of specific beta-lactamases in bacterial samples within as few as 2 to 10 minutes.
1. A kit for detecting the presence of a beta-lactamase, the kit comprising a solid support containing a dried form of a composition, wherein the composition comprises a lysis reagent and a detectable beta-lactamase substrate.
2. A kit for detecting the presence of a beta-lactamase, the kit comprising a solid support containing a dried form of a composition, wherein the composition comprises a lysis reagent, an agent that promotes the stabilization of the lysis reagent, and a detectable beta-lactamase substrate.
3. A kit for detecting the presence of a beta-lactamase, the kit comprising a solid support containing a dried form of a composition, wherein the composition comprises a lysis reagent, a carbohydrate, an agent that enhances the lysis of a bacterial cell by the lysis reagent, and a detectable beta-lactamase substrate.
4. The kit of claim 1 , wherein the composition further comprises an agent that enhances the lysis of a bacterial cell by the lysis reagent.
5. The kit of claim 1 , wherein the composition further comprises one or more beta-lactamase inhibitors.
6. The kit of claim 1 , wherein the lysis reagent is an enzyme.
7. The kit of claim 1 , wherein the lysis reagent is lysozyme, labiase, lysostaphin, achromopeptidase or mutanolysin.
8. The kit of claim 1 , wherein the detectable beta-lactamase substrate is nitrocefin, pyridinium-2-azo-p-dimethylaniline chromophore, (7R)-3-(((3-carboxy-4-nitrophenyl)thio)methyl)-8-oxo-7-(2-(thiophen-2-yl)-acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, or (7R)-7[2-aminothiazol-4-yl]-(z)-2-(1-carboxy-1-methylethoxyimino)acetamid-o)-3-(2,4-dinitrostyryl)-3-cephem-4-carboxylic acid trifluoroacetate, E-isomer.
9. The kit of claim 2 , wherein the composition further comprises one or more beta-lactamase inhibitors.
10. The kit of claim 2 , wherein the lysis reagent is an enzyme.
11. The kit of claim 2 , wherein the lysis reagent is lysozyme, labiase, lysostaphin, achromopeptidase or mutanolysin.
12. The kit of claim 2 , wherein the detectable beta-lactamase substrate is nitrocefin, pyridinium-2-azo-p-dimethylaniline chromophore, (7R)-3-(((3-carboxy-4-nitrophenyl)thio)methyl)-8-oxo-7-(2-(thiophen-2-yl)-acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, or (7R)-7[2-aminothiazol-4-yl]-(z)-2-(1-carboxy-1-methylethoxyimino)acetamid-o)-3-(2,4-dinitrostyryl)-3-cephem-4-carboxylic acid trifluoroacetate, E-isomer.
13. The kit of claim 3 , wherein the composition further comprises one or more beta-lactamase inhibitors.
14. The kit of claim 3 , wherein the lysis reagent is an enzyme.
15. The kit of claim 3 , wherein the lysis reagent is lysozyme, labiase, lysostaphin, achromopeptidase or mutanolysin.
16. The kit of claim 3 , wherein the carbohydrate is mannitol, ribose, glucose, fructose, mannose, sucrose, lactose, glycerol, Xantham gum, trehalose or a glycol.
17. The kit of claim 3 , wherein the detectable beta-lactamase substrate is nitrocefin, pyridinium-2-azo-p-dimethylaniline chromophore, (7R)-3-(((3-carboxy-4-nitrophenyl)thio)methyl)-8-oxo-7-(2-(thiophen-2-yl)-acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, or (7R)-7[2-aminothiazol-4-yl]-(z)-2-(1-carboxy-1-methylethoxyimino)acetamid-o)-3-(2,4-dinitrostyryl)-3-cephem-4-carboxylic acid trifluoroacetate, E-isomer.
18. The kit of claim 3 , wherein the agent that enhances the lysis of a bacterial cell by the lysis reagent is metal chelator.
19. The kit of claim 3 , wherein the lysis reagent is lysozyme, the carbohydrate is trehalose, and the agent that enhances the lysis of a bacterial cell by the lysis is EDTA.